Redhill Biopharma Starts Recruitment For Phase 2 Opaganib/darolutamide Combo Study In Advanced Prostate Cancer
July 2, 2025
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and Ramsay